Binita M Kamath1, Zhen Chen2, Rene Romero3, Emily M Fredericks2, Estella M Alonso4, Ronen Arnon5, James Heubi6, Paula M Hertel7, Saul J Karpen3, Kathleen M Loomes8, Karen F Murray9, Philip Rosenthal10, Kathleen B Schwarz11, Girish Subbarao12, Jeffrey H Teckman13, Yumirle P Turmelle14, Kasper S Wang15, Averell H Sherker16, Ronald J Sokol17, John C Magee2. 1. The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada. Electronic address: binita.kamath@sickkids.ca. 2. University of Michigan, Ann Arbor, MI. 3. Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA. 4. Ann and Robert H. Lurie Children's Hospital and Northwestern University, Chicago, IL. 5. Mount Sinai Medical Center, New York City, NY. 6. Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 7. Baylor College of Medicine and Texas Children's Hospital, Houston, TX. 8. The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. 9. Seattle Children's Hospital and the University of Washington School of Medicine, Seattle, WA. 10. University of California, San Francisco, CA. 11. Johns Hopkins Medical Institutions, Baltimore, MD. 12. Riley Hospital for Children, Indiana University, Indianapolis, IN. 13. Saint Louis University School of Medicine, St. Louis, MO. 14. Washington University, St. Louis, MO. 15. Children's Hospital Los Angeles, Los Angeles, CA. 16. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. 17. University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.
Abstract
OBJECTIVES: To assess health-related quality of life (HRQOL) in children with Alagille syndrome (ALGS) in comparison with healthy and other liver disease cohorts, and to identify determinants of HRQOL in patients with ALGS. STUDY DESIGN: Within the Childhood Liver Disease Research Network prospective study of cholestasis, Pediatric Quality of Life Inventory (PedsQL) questionnaires were administered to 70 children with ALGS, 95 children with alpha-1-antitrypsin deficiency (A1ATD), and 49 children with other causes of chronic intrahepatic cholestasis (IHC) aged 5-18 years. Parent proxy PedsQL scores were recorded for children aged 2-18 years (98 ALGS, 123 A1ATD, and 68 IHC). RESULTS: Mean ages and total bilirubin (mg/dL) were ALGS 9.4 years; 4.4, A1ATD 9.5 years; 0.7, and IHC 10.3 years; 2.9. ALGS child PedsQL scores were lower than in healthy children and children with A1ATD (mean 73 vs 83; P = .001). Children with ALGS and IHC were similar, except in physical scores (73 vs 79; P = .05). Parents of children with ALGS perceived their children to have worse HRQOL than A1ATD (P ≤ .001) and marginally lower compared with IHC. Univariate analysis revealed ALGS child-reported scores were positively associated with better growth and inversely with total bilirubin. Growth failure, elevated international normalized ratio, and an intracardiac defect were predictive of poor parental scores (P ≤ .05). In multivariate analysis, only weight z-score remained significant for child- and parent-reported scores. CONCLUSIONS: HRQOL is impaired in children with ALGS compared with healthy and children with A1ATD, similar to children with IHC and is associated with growth failure, which is a potentially treatable cause of impaired HRQOL.
OBJECTIVES: To assess health-related quality of life (HRQOL) in children with Alagille syndrome (ALGS) in comparison with healthy and other liver disease cohorts, and to identify determinants of HRQOL in patients with ALGS. STUDY DESIGN: Within the Childhood Liver Disease Research Network prospective study of cholestasis, Pediatric Quality of Life Inventory (PedsQL) questionnaires were administered to 70 children with ALGS, 95 children with alpha-1-antitrypsin deficiency (A1ATD), and 49 children with other causes of chronic intrahepatic cholestasis (IHC) aged 5-18 years. Parent proxy PedsQL scores were recorded for children aged 2-18 years (98 ALGS, 123 A1ATD, and 68 IHC). RESULTS: Mean ages and total bilirubin (mg/dL) were ALGS 9.4 years; 4.4, A1ATD 9.5 years; 0.7, and IHC 10.3 years; 2.9. ALGSchild PedsQL scores were lower than in healthy children and children with A1ATD (mean 73 vs 83; P = .001). Children with ALGS and IHC were similar, except in physical scores (73 vs 79; P = .05). Parents of children with ALGS perceived their children to have worse HRQOL than A1ATD (P ≤ .001) and marginally lower compared with IHC. Univariate analysis revealed ALGSchild-reported scores were positively associated with better growth and inversely with total bilirubin. Growth failure, elevated international normalized ratio, and an intracardiac defect were predictive of poor parental scores (P ≤ .05). In multivariate analysis, only weight z-score remained significant for child- and parent-reported scores. CONCLUSIONS: HRQOL is impaired in children with ALGS compared with healthy and children with A1ATD, similar to children with IHC and is associated with growth failure, which is a potentially treatable cause of impaired HRQOL.
Authors: C Crosnier; C Driancourt; N Raynaud; S Dhorne-Pollet; N Pollet; O Bernard; M Hadchouel; M Meunier-Rotival Journal: Gastroenterology Date: 1999-05 Impact factor: 22.682
Authors: Estella M Alonso; Katie Neighbors; Franca B Barton; Sue V McDiarmid; Stephen P Dunn; George V Mazariegos; Jeanne M Landgraf; John C Bucuvalas Journal: Liver Transpl Date: 2008-04 Impact factor: 5.799
Authors: E M Alonso; K Neighbors; C Mattson; E Sweet; H Ruch-Ross; C Berry; J Sinacore Journal: J Pediatr Gastroenterol Nutr Date: 2003-08 Impact factor: 2.839
Authors: Conrad R Cole; John C Bucuvalas; Richard W Hornung; Susan Krug; Frederick C Ryckman; Harry Atherton; Maria P Alonso; William F Balistreri; Uma Kotagal Journal: Pediatr Transplant Date: 2004-06
Authors: Binita M Kamath; Cathie Spino; Richard McLain; John C Magee; Emily M Fredericks; Kenneth D Setchell; Alexander Miethke; Jean P Molleston; Cara L Mack; Robert H Squires; Estella M Alonso; Karen F Murray; Kathleen M Loomes; M Kyle Jensen; Saul J Karpen; Philip Rosenthal; Danny Thomas; Ronald J Sokol; Benjamin L Shneider Journal: Hepatol Commun Date: 2020-05-26
Authors: Daniel H Leung; Lisa G Sorensen; Wen Ye; Kieran Hawthorne; Vicky L Ng; Kathleen M Loomes; Emily M Fredericks; Estella M Alonso; James E Heubi; Simon P Horslen; Saul J Karpen; Jean P Molleston; Philip Rosenthal; Ronald J Sokol; Robert H Squires; Kasper S Wang; Binita M Kamath; John C Magee Journal: J Pediatr Gastroenterol Nutr Date: 2022-01-01 Impact factor: 3.288